Gene Expression Differences Predict Treatment Outcome of Merkel Cell Carcinoma Patients

Table 1

Clinical characteristics of the 17 MCC patients utilized in study.

Feature	Good prognosis	Moderate prognosis	Poor prognosis	Total
	𝑛=6 (35%)	𝑛=3 (18%)	𝑛=8 (47%)	𝑛=17
Gender
Male	3 (50%)	2 (67%)	4 (50%)	9 (53%)
Female	3 (50%)	1 (33%)	4 (50%)	8 (47%)
Age, years: median, range	71.7 (54–82)	78.7 (71–84)	68.8 (44–83)
Location
Head and neck	3 (50%)	1 (33%)	2 (25%)	6 (35%)
Upper extremity	2 (33%)	1 (33%)	2 (25%)	5 (30%)
Lower extremity	1 (17%)	0 (0%)	3 (37.5%)	4 (23%)
Torso	0 (0%)	1 (33%)	1 (12.5%)	2 (12%)
AJCC stage at diagnosis
(I)	2 (33%)	1 (33%)	0 (0%)	3 (18%)
(II)	3 (50%)	2 (67%)	5 (62.5%)	10 (59%)
(III)	1 (17%)	0 (0%)	3 (37.5%)	4 (23%)